0001127602-15-000618.txt : 20150105 0001127602-15-000618.hdr.sgml : 20150105 20150105161027 ACCESSION NUMBER: 0001127602-15-000618 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150101 FILED AS OF DATE: 20150105 DATE AS OF CHANGE: 20150105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babu Yarlagadda S CENTRAL INDEX KEY: 0001452635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 15504813 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-01-01 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001452635 Babu Yarlagadda S 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - Drug Discovery Common Stock 2015-01-01 4 A 0 8900 0 A 217095 D Common Stock 2015-01-01 4 F 0 2402 12.16 D 214693 D Emp. Stock Option (Right to Buy) 12.16 2015-01-01 4 A 0 42400 0 A 2016-01-01 2025-01-01 Common Stock 42400 42400 D Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. Shares withheld by BioCryst Pharmaceuticals, Inc. to satisfy the reporting person's withholding obligations upon the vesting of restricted stock units granted in 2013. Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. /s/ Alane P. Barnes, by power of attorney 2015-01-05